Abstract
Pre-eclampsia (PE) and eclampsia remain important causes of maternal and perinatal morbidity in West Africa, but the regional evidence on their hematological features is fragmented. This structured narrative review searched PubMed/MEDLINE, Google Scholar, African Journals Online, medical theses, and the digital repositories of Université Cheikh Anta Diop and Université Assane Seck de Ziguinchor through 20 July 2026. West African original studies were prioritized; international guidelines and high-quality reviews were used for definitions and contextual comparison. Available regional studies are mostly small, single-center, cross-sectional or retrospective. They suggest that thrombocytopenia, anemia, and coagulation abnormalities are more frequent in severe or complicated disease, but reported associations with platelet indices, inflammatory ratios, antiphospholipid antibodies, and inherited thrombophilia are inconsistent. A full blood count with platelet count is central to assessment. Tests for hemolysis and coagulation should be guided by severity, suspected hemolysis, bleeding, placental abruption, or disseminated intravascular coagulation. Current evidence does not support routine D-dimer, platelet-index, inflammatory-ratio, antiphospholipid-antibody or inherited-thrombophilia panels for every patient with PE. Multicenter prospective studies using standard definitions and clinically relevant outcomes are required to identify markers that improve care in West African settings.
Keywords
Pre-eclampsia, Eclampsia, Hematological aspects, Thrombocytopenia, Hemostasis, Antiphospholipid antibodies, Thrombophilia, HELLP syndrome, Maternal–fetal complications, West Africa